PDCD1 and neoplasm: ICI is capable of restoring T cell-mediated tumor cell killing and depleting regulatory Tregs by blocking immune checkpoint molecules (e.g., cytotoxic T lymphocyte antigen 4 (CTLA4), PD-L1, as well as PD-1.